Profitelligence Profitelligence · Filing Ledger Open COR research →

Form 8-K · Current Report · Filed 2025-07-03

Cencora, Inc. Announces Amendment to Securitization Facility

On June 30, 2025, Cencora, Inc. announced the Twenty-Second Amendment to its Amended and Restated Receivables Purchase Agreement, which increased the facility size to $1.5 billion and expanded the Accordion Feature to $500 million. This amendment provides additional liquidity for the company's ongoing business needs.

Filer
Cencora Inc. COR · NYSE
Filed
Accession
0001104659-25-065769
CIK
0001140859
Signal
Medium impactHealthcare

Items reported

Item 1.01

Entry into a Material Definitive Agreement

Material Agreement Amendment
Item 2.03

Creation of a Direct Financial Obligation

New Debt Issued
Item 9.01

Financial Statements and Exhibits

No viable tag

Market reaction

Close before filing

$291.17

Next session

+3.9%

Since filing

+6.9%

Latest close

$311.34

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from COR reporting the same item, with the next session's move:

Exhibits (1)

About Cencora Inc.

Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.

Exchange NYSE Industry Medical Distribution Company website ↗

Never miss another COR filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts